32.30
price up icon0.50%   0.16
after-market Dopo l'orario di chiusura: 32.30
loading

Viking Therapeutics Inc Azioni (VKTX) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Operating Expenses
34.44%
74.57
55.47 46.24 36.56 34.05
Operating Income/Loss
34.44%
-74.57
-55.47 -46.24 -36.56 -34.05
Income/Loss From Continuing Operations Before Tax
43.68%
-65.56
-45.63 -35.42 -24.94 -22.25
Income/Loss From Continuing Operations After Tax
43.68%
-65.56
-45.63 -35.42 -24.94 -22.25
Net Income/Loss
43.68%
-65.56
-45.63 -35.42 -24.94 -22.25
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.06%
112.13
112.07 0.775 110.91 110.39
Diluted Average Shares
0.06%
112.13
112.07 0.775 110.91 110.39
Basic Earnings Per Share
41.46%
-0.58
-0.41 -0.32 -0.22 -0.20
Diluted Earnings Per Share
41.46%
-0.58
-0.41 -0.32 -0.22 -0.20
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$40.65
price up icon 2.52%
$33.10
price up icon 4.09%
$106.66
price up icon 4.78%
$98.09
price up icon 1.28%
biotechnology ONC
$320.35
price up icon 0.02%
$175.07
price down icon 0.07%
Capitalizzazione:     |  Volume (24 ore):